Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions

J Clin Invest. 2021 Dec 15;131(24):e155499. doi: 10.1172/JCI155499.

Authors

Rory D de Vries¹, Marieke van der Heiden², Daryl Geers¹, Celine Imhof³, Debbie van Baarle^{2

4}; RECOVAC-IR Collaborators

Affiliations

¹ Department Viroscience, Erasmus MC, Rotterdam, Netherlands.
² Department of Medical Microbiology and Infection Prevention and.
³ Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands.
⁴ Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.

No abstract available

Keywords: Adaptive immunity; Immunology; T cells; Virology.

Publication types

Comment

MeSH terms

Adaptive Immunity
COVID-19*
Humans
Immunity, Humoral
SARS-CoV-2*
T-Lymphocytes